Martin J F, Vierling J M, Wolkoff A W, Scharschmidt B F, Vergalla J, Waggoner J G, Berk P D
Gastroenterology. 1976 Mar;70(3):385-91.
The plasma fractional disappearance rate of indocyanine green (kICG, min-1) and the absolute hepatic ICG removal rate (VICG, mg per kg per min) were determined in 26 patients with Gilbert's syndrome (GS) and 19 normal control volunteers following intravenous administration of doses of 0.5, 2.0, 3.5, and 5.0 mg per kg of dye. The diagnosis of GS was based on studies of radiobilirubin kinetics in all cases and liver biopsy in 22 cases. The patients were further classified into 3 subgroups, based on patterns of sulfobromophthalein (BSP) kinetics, as follows: GS I (15 patients) had normal BSP metabolism; GS II (5 patients) had a defect in BSP metabolism beyond the stage of initial hepatic uptake; and GS III (6 patients) had a defect in the initial hepatic uptake of BSP (Gastroenterology 63:472-481, 1972). Both kICG and VICG were significantly reduced, compared to normal controls, in the GS III group with defective BSP uptake, but did not differ significantly from normal in the GS I and GS II groups. Michaelis-Menten analysis of the data indicated that VMAX for ICG uptake in the GS III group (1.2 +/- 0.6 mg per min per kg) was significantly reduced compared to the previously established normal value of 3.6 +/- 0.6 mg per min per kg; (P less than 0.01). For the total population of 26 patients with Gilbets' syndrome, there was a highly significant correlation (r= 0.77, P less than 0.01) between kICG and lambda21BSP, the fractional hepatic uptake rate for BSP. These studies confirm previous work indicating that patients with Gilbert's syndrome constitute a heterogeneous population with regard to defects in hepatic organic anion transport, some of the defects not being attributable to glucuronyl transferese deficiency. Future studies of Gilbert's syndrome must take into account the existence of these subgroups, since they may have different underlying pathogenetic mechanisms.
在26例吉尔伯特综合征(GS)患者和19名正常对照志愿者静脉注射每千克体重0.5、2.0、3.5和5.0毫克染料后,测定了吲哚菁绿的血浆分数消失率(kICG,分钟⁻¹)和肝脏吲哚菁绿绝对清除率(VICG,每千克每分钟毫克数)。所有病例的GS诊断均基于放射性胆红素动力学研究,22例进行了肝活检。根据磺溴酞钠(BSP)动力学模式,患者进一步分为3个亚组,如下:GS I(15例患者)BSP代谢正常;GS II(5例患者)BSP代谢在初始肝脏摄取阶段之后存在缺陷;GS III(6例患者)BSP初始肝脏摄取存在缺陷(《胃肠病学》63:472 - 481,1972)。与正常对照相比,BSP摄取存在缺陷的GS III组中,kICG和VICG均显著降低,但GS I组和GS II组与正常对照无显著差异。对数据进行米氏分析表明,GS III组中ICG摄取的VMAX(每分钟每千克1.2±0.6毫克)与先前确定的正常数值每分钟每千克3.6±0.6毫克相比显著降低;(P<0.01)。对于26例吉尔伯特综合征患者的总体人群,kICG与BSP的肝脏分数摄取率lambda21BSP之间存在高度显著的相关性(r = 0.77,P<0.01)。这些研究证实了先前的工作,表明吉尔伯特综合征患者在肝脏有机阴离子转运缺陷方面构成了一个异质性群体,其中一些缺陷并非归因于葡萄糖醛酸转移酶缺乏。未来对吉尔伯特综合征的研究必须考虑到这些亚组的存在,因为它们可能具有不同的潜在发病机制。